These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 8340682)

  • 1. Cardiac transplantation: role of endomyocardial biopsy and immunosuppressive agents.
    Eiswirth CC; Smart FW
    J La State Med Soc; 1993 May; 145(5):203-6. PubMed ID: 8340682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should we be doing routine biopsy after heart transplantation in a new era of anti-rejection?
    Patel JK; Kobashigawa JA
    Curr Opin Cardiol; 2006 Mar; 21(2):127-31. PubMed ID: 16470149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of surveillance biopsies in infant heart transplant recipients.
    Balzer DT; Moorhead S; Saffitz JE; Huddleston CB; Spray TL; Canter CE
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1095-101. PubMed ID: 8719456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis, surveillance, and epidemiologic evaluation of viral infections in pediatric cardiac transplant recipients with the use of the polymerase chain reaction.
    Schowengerdt KO; Ni J; Denfield SW; Gajarski RJ; Radovancevic B; Frazier HO; Demmler GJ; Kearney D; Bricker JT; Towbin JA
    J Heart Lung Transplant; 1996 Feb; 15(2):111-23. PubMed ID: 8672514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute rejection and heart infection rates in FK 506- versus cyclosporine A-treated heart transplant recipients: an endomyocardial biopsy pathologic study.
    Arbustini E; Dal Bello B; Rinaldi M; Diegoli M; Grasso M; Pellegrini C; Morbini P; Martinelli L; Bonora MR; Viganò M
    J Heart Lung Transplant; 1997 Sep; 16(9):982-4. PubMed ID: 9322152
    [No Abstract]   [Full Text] [Related]  

  • 6. Consistencies and controversies in the application of the International Society for Heart and Lung Transplantation working formulation for heart transplant biopsy specimens. Rapamycin Cardiac Rejection Treatment Trial Pathologists.
    Winters GL; McManus BM
    J Heart Lung Transplant; 1996 Jul; 15(7):728-35. PubMed ID: 8820790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The significance of eosinophils in mild and moderate acute cardiac allograft rejection.
    Gollub SB; Huntrakoon M; Dunn MI
    Am J Cardiovasc Pathol; 1990; 3(1):21-6. PubMed ID: 2331359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can non-invasive methodology predict rejection and either dictate or obviate the need for an endomyocardial biopsy in pediatric heart transplant recipients?
    Hsu DT
    Pediatr Transplant; 2005 Dec; 9(6):697-9. PubMed ID: 16269038
    [No Abstract]   [Full Text] [Related]  

  • 9. The pathology of transplanted hearts.
    Billingham ME
    Semin Thorac Cardiovasc Surg; 1990 Jul; 2(3):233-40. PubMed ID: 2081231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Routine surveillance myocardial biopsies are unnecessary beyond one year after heart transplantation.
    White JA; Guiraudon C; Pflugfelder PW; Kostuk WJ
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1052-6. PubMed ID: 8719450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac allograft rejection: do trough cyclosporine levels correlate with the grade of histologic rejection?
    el Gamel A; Keevil B; Rahman A; Campbell C; Deiraniya A; Yonan N
    J Heart Lung Transplant; 1997 Mar; 16(3):268-74. PubMed ID: 9087869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent histologic evidence of rejection in a heart transplant recipient without evidence of graft dysfunction.
    Nakhleh RE; Kubo SH; Olivari MT; McDonald K
    J Heart Lung Transplant; 1992; 11(1 Pt 1):37-41. PubMed ID: 1540610
    [No Abstract]   [Full Text] [Related]  

  • 13. [A critical review of the role of endomyocardial biopsy in heart transplantation].
    Vázquez de Prada JA
    Rev Esp Cardiol; 1995; 48 Suppl 7():86-91. PubMed ID: 8775822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Timing of the first endomyocardial biopsy in heart transplantation after induction immunosuppressive therapy--experience from Canadian Heart Transplant Centre.
    Málek F; Kaan A; Straatman L; Cheung A; Gnaszewski A
    Cas Lek Cesk; 2005; 144(8):507-9; discussion 509. PubMed ID: 16173602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic validity of hepatocyte growth factor as marker for rejection in the follow-up of patients after heart transplantation.
    Zwirska-Korczala K; Zakliczyński M; Berdowska A; Zembala M; Jochem J; Gajewska K
    J Heart Lung Transplant; 2005 Apr; 24(4):411-5. PubMed ID: 15797741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocytolysis in heart transplant patients.
    Sgrosso JL; Parisi C; Ahualli L; Romeo L; Esteban W; Cammarata C
    Transplant Proc; 1996 Dec; 28(6):3325-7. PubMed ID: 8962291
    [No Abstract]   [Full Text] [Related]  

  • 17. Pathology of cardiac transplantation--the initial experience.
    Chopra P; Joshi A; Talwar KK; Airan B; Srivastava S; Venugopal P
    Natl Med J India; 1997; 10(6):264-9. PubMed ID: 9481095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pathology of the heart transplant].
    Sánchez-Vegazo I; Sanz E; Anaya A
    Rev Esp Cardiol; 1995; 48 Suppl 7():65-70. PubMed ID: 8775819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unsuspected rejection episodes on routine surveillance endomyocardial biopsy post-heart transplant in paediatric patients.
    Dixon V; Macauley C; Burch M; Sebire NJ
    Pediatr Transplant; 2007 May; 11(3):286-90. PubMed ID: 17430484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term management and results in heart transplant recipients.
    Valantine HA
    Cardiol Clin; 1990 Feb; 8(1):141-8. PubMed ID: 2407355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.